Hepatocyte viability and protein expression within hydrogel microstructures

Laura J. Itle, Won Gun Koh, Michael V. Pishko

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Poly(ethylene) glycol (PEG) hydrogels have been successfully used to entrap mammalian cells for potential high throughput drug screening and biosensing applications. To determine the influence of PEG composition on the production of cellular protein, mammalian hepatocytes were maintained in PEG hydrogels for 7 days. Total cell viability, total protein production, and the production of two specific proteins, albumin and fibronectin, were monitored. Studies revealed that while PEG composition has no effect on cell viability, increasing amounts of PEG in the hydrogel decrease the amount of protein production by the cells after 7 days from 1.0 × 105 ± 1.7 × 104 to 5.2 × 103 ± 1.3 × 103 g accumulated protein/mL/million cells. Additionally, cells entrapped in PEG hydrogels produce greater amounts of protein than traditional monolayer culture (1.5 × 103 ± 1.9 × 102 g accumulated protein/mL/million cells after 7 days). The addition of the synthetic peptide RGD to 10% PEG hydrogels altered the production of the proteins albumin and fibronectin. Hydrogels with the RGD sequence produced 287 ± 27 ng/mL/million cells albumin after 7 days, an order of magnitude greater than monolayer cultures, whereas cells in hydrogels without the RGD sequence produced undetectable levels of albumin. Conversely, cells entrapped in 10% PEG hydrogels without the RGD sequence produced 1014 ± 328 ng/mL/million cells fibronectin after 7 days, whereas 10% PEG hydrogels with the RGD sequence produced 200 ± 58 ng/mL/million cells fibronectin after 7 days.

Original languageEnglish
Pages (from-to)926-932
Number of pages7
JournalBiotechnology Progress
Volume21
Issue number3
DOIs
Publication statusPublished - 2005 May 1

Fingerprint

Hydrogel
hydrocolloids
Hydrogels
microstructure
hepatocytes
Hepatocytes
protein synthesis
viability
fibronectins
Fibronectins
Proteins
albumins
Albumins
cells
proteins
cell viability
Cell Survival
Preclinical Drug Evaluations
Ethylene Glycol
synthetic peptides

All Science Journal Classification (ASJC) codes

  • Biotechnology

Cite this

Itle, Laura J. ; Koh, Won Gun ; Pishko, Michael V. / Hepatocyte viability and protein expression within hydrogel microstructures. In: Biotechnology Progress. 2005 ; Vol. 21, No. 3. pp. 926-932.
@article{82af8b77e3e04a6294d4afaceff9b322,
title = "Hepatocyte viability and protein expression within hydrogel microstructures",
abstract = "Poly(ethylene) glycol (PEG) hydrogels have been successfully used to entrap mammalian cells for potential high throughput drug screening and biosensing applications. To determine the influence of PEG composition on the production of cellular protein, mammalian hepatocytes were maintained in PEG hydrogels for 7 days. Total cell viability, total protein production, and the production of two specific proteins, albumin and fibronectin, were monitored. Studies revealed that while PEG composition has no effect on cell viability, increasing amounts of PEG in the hydrogel decrease the amount of protein production by the cells after 7 days from 1.0 × 105 ± 1.7 × 104 to 5.2 × 103 ± 1.3 × 103 g accumulated protein/mL/million cells. Additionally, cells entrapped in PEG hydrogels produce greater amounts of protein than traditional monolayer culture (1.5 × 103 ± 1.9 × 102 g accumulated protein/mL/million cells after 7 days). The addition of the synthetic peptide RGD to 10{\%} PEG hydrogels altered the production of the proteins albumin and fibronectin. Hydrogels with the RGD sequence produced 287 ± 27 ng/mL/million cells albumin after 7 days, an order of magnitude greater than monolayer cultures, whereas cells in hydrogels without the RGD sequence produced undetectable levels of albumin. Conversely, cells entrapped in 10{\%} PEG hydrogels without the RGD sequence produced 1014 ± 328 ng/mL/million cells fibronectin after 7 days, whereas 10{\%} PEG hydrogels with the RGD sequence produced 200 ± 58 ng/mL/million cells fibronectin after 7 days.",
author = "Itle, {Laura J.} and Koh, {Won Gun} and Pishko, {Michael V.}",
year = "2005",
month = "5",
day = "1",
doi = "10.1021/bp049681i",
language = "English",
volume = "21",
pages = "926--932",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Hepatocyte viability and protein expression within hydrogel microstructures. / Itle, Laura J.; Koh, Won Gun; Pishko, Michael V.

In: Biotechnology Progress, Vol. 21, No. 3, 01.05.2005, p. 926-932.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatocyte viability and protein expression within hydrogel microstructures

AU - Itle, Laura J.

AU - Koh, Won Gun

AU - Pishko, Michael V.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - Poly(ethylene) glycol (PEG) hydrogels have been successfully used to entrap mammalian cells for potential high throughput drug screening and biosensing applications. To determine the influence of PEG composition on the production of cellular protein, mammalian hepatocytes were maintained in PEG hydrogels for 7 days. Total cell viability, total protein production, and the production of two specific proteins, albumin and fibronectin, were monitored. Studies revealed that while PEG composition has no effect on cell viability, increasing amounts of PEG in the hydrogel decrease the amount of protein production by the cells after 7 days from 1.0 × 105 ± 1.7 × 104 to 5.2 × 103 ± 1.3 × 103 g accumulated protein/mL/million cells. Additionally, cells entrapped in PEG hydrogels produce greater amounts of protein than traditional monolayer culture (1.5 × 103 ± 1.9 × 102 g accumulated protein/mL/million cells after 7 days). The addition of the synthetic peptide RGD to 10% PEG hydrogels altered the production of the proteins albumin and fibronectin. Hydrogels with the RGD sequence produced 287 ± 27 ng/mL/million cells albumin after 7 days, an order of magnitude greater than monolayer cultures, whereas cells in hydrogels without the RGD sequence produced undetectable levels of albumin. Conversely, cells entrapped in 10% PEG hydrogels without the RGD sequence produced 1014 ± 328 ng/mL/million cells fibronectin after 7 days, whereas 10% PEG hydrogels with the RGD sequence produced 200 ± 58 ng/mL/million cells fibronectin after 7 days.

AB - Poly(ethylene) glycol (PEG) hydrogels have been successfully used to entrap mammalian cells for potential high throughput drug screening and biosensing applications. To determine the influence of PEG composition on the production of cellular protein, mammalian hepatocytes were maintained in PEG hydrogels for 7 days. Total cell viability, total protein production, and the production of two specific proteins, albumin and fibronectin, were monitored. Studies revealed that while PEG composition has no effect on cell viability, increasing amounts of PEG in the hydrogel decrease the amount of protein production by the cells after 7 days from 1.0 × 105 ± 1.7 × 104 to 5.2 × 103 ± 1.3 × 103 g accumulated protein/mL/million cells. Additionally, cells entrapped in PEG hydrogels produce greater amounts of protein than traditional monolayer culture (1.5 × 103 ± 1.9 × 102 g accumulated protein/mL/million cells after 7 days). The addition of the synthetic peptide RGD to 10% PEG hydrogels altered the production of the proteins albumin and fibronectin. Hydrogels with the RGD sequence produced 287 ± 27 ng/mL/million cells albumin after 7 days, an order of magnitude greater than monolayer cultures, whereas cells in hydrogels without the RGD sequence produced undetectable levels of albumin. Conversely, cells entrapped in 10% PEG hydrogels without the RGD sequence produced 1014 ± 328 ng/mL/million cells fibronectin after 7 days, whereas 10% PEG hydrogels with the RGD sequence produced 200 ± 58 ng/mL/million cells fibronectin after 7 days.

UR - http://www.scopus.com/inward/record.url?scp=20144375849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144375849&partnerID=8YFLogxK

U2 - 10.1021/bp049681i

DO - 10.1021/bp049681i

M3 - Article

C2 - 15932275

AN - SCOPUS:20144375849

VL - 21

SP - 926

EP - 932

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 3

ER -